awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35164938-EF473C60-E846-42B5-BE58-30A9ADB25E0B
Q35164938-EF473C60-E846-42B5-BE58-30A9ADB25E0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35164938-EF473C60-E846-42B5-BE58-30A9ADB25E0B
Current neoadjuvant treatment options for HER2-positive breast cancer.
P2860
Q35164938-EF473C60-E846-42B5-BE58-30A9ADB25E0B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35164938-EF473C60-E846-42B5-BE58-30A9ADB25E0B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1958581afd0dff68be26489c861c7c1c3f671c6f
P2860
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized